Loading clinical trials...
Loading clinical trials...
The main objectives of this study are: 1. Improve genetic counseling by establishment of prevalences of each of genetic subtypes within a expanded population of patients with LCA taking into account ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT01208389 · Leber Congenital Amaurosis
NCT06088992 · Leber Congenital Amaurosis
NCT03913130 · Leber Congenital Amaurosis 10, Blindness, and more
NCT02946879 · Leber Congenital Amaurosis (LCA), Eye Diseases, and more
NCT00821340 · Leber Congenital Amaurosis
Necker-Enfants Malades Hospital
Paris, Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions